Senior Machine Learning Scientist I, Drug Discovery Analytics
About the Role
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective…
Unlock the apply link on every AI job
Browsing is free. Membership is $9 a year or $4.90 every three months and unlocks the apply link and the full description on every job. Cancel any time from your billing page.
- The apply link on every job, straight to the official posting
- Full job descriptions instead of the preview
- Every AI job, every day: thousands of listings from 1,000+ company career pages
- Save jobs and get daily alerts for your categories
Secure checkout by Dodo Payments·Cancel anytime from your billing page